PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following healthcare conferences in September: H.C. Wainwright & Co. Annual Global Investment Conference Tuesday, September 13 at 10:30 a.m. ET Ladenburg Thalmann Healthcare Conference … [Read more…]
Solution offers ready-to-use, provider performance metrics that can be integrated into front-end and back-end healthcare applications to inform both critical business and clinical decisions ARLINGTON, Va.–(BUSINESS WIRE)–CareJourney, the healthcare industry’s leading source of provider cost and quality data, today announced enhancements to its provider performance module on the CareJourney platform. The module can be accessed … [Read more…]
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners (Linden). Jordi Labs provides a full suite of regulatory, investigative and other related analytical chemistry testing services primarily to medical device manufacturers. The transaction was … [Read more…]
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Affordablemedicines–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch, in the U.S. market, of Lenalidomide Capsules, a therapeutic equivalent generic version of REVLIMID® (lenalidomide) Capsules approved by U.S. Food and Drug Administration … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Continuous Bioprocessing Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Continuous Bioprocessing Market is projected to reach USD 18,067.04 million by 2027 from USD 8,795.43 million in 2021, at a CAGR 12.74% during the forecast period. Market Statistics: The report provides market sizing and … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Chronic Pain Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Chronic Pain market. It covers emerging therapies for Chronic Pain in active clinical development stages including early and late stage clinical trials. The … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–Neomorph, Inc., a venture backed biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets,’ today announced the appointment of Bell Zhong as the company’s Chief Financial Officer. Mr. Zhong brings to Neomorph more than 17 years of investment banking and corporate finance … [Read more…]
BROOKLYN, N.Y.–(BUSINESS WIRE)–#Dialysis–In anticipation of Nephrology Nurses Week, Dialyze Direct, the nation’s leading provider of home hemodialysis services in skilled nursing facilities (SNFs), joins the American Nephrology Nurses Association (ANNA) and its SNF partners around the country September 11-17 in honoring the dedicated and compassionate nephrology nurses who provide hemodialysis and other lifesaving services to … [Read more…]
STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 2:00 pm Eastern Time. The conference is being held as … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Induced Pluripotent Stem Cells Market – Growth, Trends, Covid-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Induced Pluripotent Stem Cells Market is projected to register a CAGR of 8.4% during the forecast period (2022 to 2027). Companies Mentioned Axol Bioscience Ltd. Cynata Therapeutics Limited Evotec SE … [Read more…]
